BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Adipose tissue
,
Autoimmunity
,
Cisplatin
,
rs3825942
,
CYP51
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
component viral
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Congenital disorder
OMIM - Unspecified immunity deficiency
Splenic CD8+ T cells post LCMV infection and spleen specific T-regulatory cells (T-reg) depletion
Cancer Gene Census - mutations in cancer genes
OMIM - Metabolic disease
Explore Curated Studies Results
Literature
Most Relevant Literature
Genomic analysis of Pseudomonas putida phage tf with localized single-strand DNA interruptions.
Nonstructural protein NS80 is crucial in recruiting viral components to form aquareoviral factories.
Genomic organization and recombination analysis of human norovirus identified from China.
Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infecti…
A reverse genetics system for the Great Lakes strain of viral hemorrhagic septicemia virus: the NV g…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression
Immune and Viral Outcomes of HIV-1 Therapy Interruption
A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Safety, and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ